U.S. In-Vitro Fertilization (IVF) Market Research Report 2021-2026 - Technological Advances & Innovations And Single Parents & Same-Sex Couples Taking Infertility Treatments

DUBLIN, July 28, 2021 /PRNewswire/ -- The "U.S.
Author:
Publish date:

DUBLIN, July 28, 2021 /PRNewswire/ -- The "U.S. In-Vitro Fertilization (IVF) Market - Industry Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The U.S. in-vitro fertilization market by revenue is expected to grow at a CAGR of 5.45% during the period 2021-2026.Over the past few years, the infertility treatment market has been growing at a healthy rate because of rising awareness regarding the availability of various infertility treatment options through the government. Vendors advocating IVF awareness and campaigns are increasing the acceptance of IVF procedures and a surge in fertility tourism, which boosts the growth of the U.S.

IVF market. Technological advancements and innovations are being majorly focused on by the fertility clinics and fertility treatment centers to improve the treatment outcomes, surging the growth of the IVF market. Some modern in-vitro fertilization technologies are assisted hatching, Cult-Active, EmbryoGen, Embryo glue, and Intracytoplasmic sperm injection.

Investors are purchasing and acquiring fertility clinics with a high success rate of fertility treatment. New investors are discovering the attractiveness of infertility treatment after seeing the success of recent investments and establishing fertility clinics with sophisticated infrastructure. KEY HIGHLIGHTS

  • The consumables segment is likely to witness the highest absolute growth of 43.16% in the U.S. in-vitro fertilization (IVF) market during the forecast period compared to media and equipment product segments.
  • As the market is witnessing the increased demand for infertility treatments, this created huge competition among the vendors to offer a wide range of innovative media, consumables, and the devices necessary for infertility treatment.
  • Japan, India, and the U.S. have a greater number of in-vitro fertilization clinics compared to other countries.

VENDOR LANDSCAPEThe US in-vitro fertilization market is characterized by the presence of global, regional, and local vendors. In recent years, the global infertility treatment market has witnessed many strategic initiatives by key vendors, which is expected to intensify market competitiveness in the upcoming years. Infertility treatment is a niche industry with high margins for manufacturers, especially for vendors offering equipment, media, and related consumables, that are widely used during ART procedures. Players are expected to have active participation in the U.S. in-vitro fertilization market to maximize profit. Prominent Vendors

  • The Cooper Companies
  • Cook Medical
  • Vitrolife
  • FUJIFILM Irvine Scientific
  • Merck Group
  • Hamilton Thorne

Other Prominent Vendors

  • CARL ZEISS
  • Kitazato USA
  • Rocket Medical
  • Thermo Fisher Scientific
  • Thomas Medical
  • Nidacon
  • Esco Lifesciences
  • GYNEMED

KEY QUESTIONS ANSWERED:1. How big is the U.S. IVF market?2. What is the growth rate of the US in vitro fertilization (IVF) market?3. Which segment accounted for the largest in-vitro fertilization market share?4. Who are the key players in the US in-vitro fertilization market?5. What are some of the technological advancements and innovations in the IVF market? Key Topics Covered: 1 Research Methodology 2 Research Objectives 3 Research Process 4 Scope & Coverage4.1 Market Definition4.1.1 Inclusions4.1.2 Exclusions4.1.3 Market Estimation Caveats4.2 Base Year4.3 Scope of the Study4.3.1 Market Segmentation by Products4.3.2 Market Segmentation by Procedures4.3.3 Market Segmentation by End-Users 5 Report Assumptions & Caveats5.1 Key Caveats5.2 Currency Conversion5.3 Market Derivation 6 Market at a Glance 7 Introduction7.1 Infertility Overview7.2 IVF Treatment Overview 8 Market Opportunities & Trends8.1 Technological Advances & Innovations in IVF8.2 Single Parents & Same-Sex Couples Taking Infertility Treatments8.3 Financial Assistance Programs & Employer Benefits for Infertility Treatment8.4 Private Equity/Venture Capital Funding in IVF Clinics 9 Market Growth Enablers9.1 Increasing Prevalence of Infertility9.2 Rising Obesity Cases9.3 Increasing Acceptance of Art Procedures9.4 Rise in Number of Fertility Clinics 10 Market Restraints10.1 Lack of Standardized Government Regulations10.2 High Cost of IVF10.3 Ethical Challenges Related to IVF Treatment10.4 Limitations & Risks Associated with IVF Treatment10.5 COVID-19 Adversely Impacting IVF Procedural Volumes 11 Market Landscape11.1 Market Overview11.2 Market Size & Forecast11.2.1 Product Insights11.2.2 End-Users Insights11.2.3 Donor Type Insights11.3 Five Forces Analysis 12 Product12.1 Market Snapshot & Growth Engine12.2 Market Overview12.3 Consumables12.4 Media12.5 Equipment 13 End-Users13.1 Market Snapshot & Growth Engine13.2 Market Overview13.3 Fertility Clinics13.4 Hospitals 14 Donor Type14.1 Market Snapshot & Growth Engine14.2 Market Overview14.3 Fresh Non-Donor14.4 Frozen Non-Donor14.5 Fresh Donor14.6 Frozen Donor 15 Competitive Landscape15.1 Competition Overview15.2 Market Share Analysis

For more information about this report visit https://www.researchandmarkets.com/r/bqlw5b

Media Contact:

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com    For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716

View original content: https://www.prnewswire.com/news-releases/us-in-vitro-fertilization-ivf-market-research-report-2021-2026---technological-advances--innovations-and-single-parents--same-sex-couples-taking-infertility-treatments-301343012.html

SOURCE Research and Markets